Major Adverse Cardiovascular Events Following Vaginal Estrogen Therapy 2004–2023

Gabriella Rustia, Jessica Abou-Zeki, Jennifer Murphy, Annas Rahman, David Sheyn

Open source

DOI
10.1097/spv.0000000000001949
Published
2026-11-04
Container
Urogynecology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/spv.0000000000001949,
  title = {Major Adverse Cardiovascular Events Following Vaginal Estrogen Therapy 2004–2023},
  author = {Gabriella Rustia and Jessica Abou-Zeki and Jennifer Murphy and Annas Rahman and David Sheyn},
  year = {2026},
  journal = {Urogynecology},
  doi = {10.1097/spv.0000000000001949},
  url = {https://doi.org/10.1097/spv.0000000000001949}
}

RIS

TY  - JOUR
TI  - Major Adverse Cardiovascular Events Following Vaginal Estrogen Therapy 2004–2023
AU  - Gabriella Rustia
AU  - Jessica Abou-Zeki
AU  - Jennifer Murphy
AU  - Annas Rahman
AU  - David Sheyn
PY  - 2026
JO  - Urogynecology
DO  - 10.1097/spv.0000000000001949
UR  - https://doi.org/10.1097/spv.0000000000001949
ER  - 

APA

Rustia, G., Abou-Zeki, J., Murphy, J., Rahman, A., & Sheyn, D. (2026). Major Adverse Cardiovascular Events Following Vaginal Estrogen Therapy 2004–2023. Urogynecology. https://doi.org/10.1097/spv.0000000000001949

Source records